After a certain point, repeated organ failure assessment may be neither practical nor necessary. Some suggest that only very early changes in organ function responses (within 1 d) are truly associated with organ failure data (4) . The objective of this study is to identify a point in the ICU stay after which mortality prediction no longer improves with additional organ failure data collected over time. What predictive value do clinicians, patients, and families gain from the data, and what is sacrificed to achieve that gain?
MATERIALS AND METHODS

Study Population
Patients 18 years old or older with suspected sepsis in the ICU, defined by the following: two of four systemic inflammatory response syndrome (SIRS) criteria (5) within 4 hours of each other and had a blood culture ordered (indicating suspicion of infection), all within 24 hours. They must have been admitted to the ICU for at least 2 calendar days from ICU admission (to compare SOFA scores from at least 2 different days). Patients were excluded for any of the following: 1) they were transferred from an outside hospital; 2) they were not admitted through the emergency department (ED), or that information was unknown; or 3) they were admitted to the ICU greater than 72 hours from ED presentation (a surrogate to exclude inpatient ward transfers to the ICU). Only the first ICU stay within a single hospital admission was included in the study. Data were obtained on patients for the first 7 days of their ICU stay, or until ICU discharge or death, whichever came first.
Statistical Analysis
Though the primary model outcome was ICU mortality (with hospital mortality was a secondary model outcome), the primary "objective" was to note independent "improvement" in ICU mortality prediction with incremental addition of daily SOFA scores to a multivariate model. The primary "exposures" of interest were the SOFA scores from ICU calendar days 1 to 7.
The SOFA score for a given ICU day was based on the sum of the worst scores for all component organ failures in that calendar day. Evidence of neurologic, respiratory, cardiovascular, renal, hematologic, and hepatic dysfunction were extracted every other day for the first 7 days of ICU admission. Our dataset did not include doses of vasoactive agents, therefore cardiovascular dysfunction over a score of 1 was based on whether a drug was administered regardless of dose. All other organ failure calculations were based on the original SOFA score definitions (Appendix Table 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/C851) (6) . Component organ scores were assigned a value of 0 if the raw data from which they were derived was missing or nonsensical (e.g., a partial pressure of oxygen of 1 mm Hg).
Demographic characteristics, comorbid illness data, and other hospital course variables were also examined. Patient demographic covariates included age, sex, and race. Chronic comorbid illnesses were examined using the Charlson-Deyo comorbidity index (CCI) (7, 8) . Hospital course data included the type of ICU(s) to which patients were admitted and abnormal SIRS variables at ICU admission.
A derivation cohort was selected to construct all models. Bivariate analyses were conducted to assess the relationship between each candidate predictor and mortality. All continuous variables were assessed for normality and analyzed using Student's t test or Wilcoxon rank-sum test, as appropriate. Categorical variables were analyzed using Pearson's chi-square. Only candidate variables associated with mortality on bivariate analysis with a p value of less than 0.25 were eligible for inclusion as covariates in multivariable logistic regression models.
The cohort was stratified into six "subcohorts" (Fig. 1) to account for patient attrition and statistically assess the effect of adding SOFA scores from days following ICU admission (for patient characteristics of each subcohort, see Appendix Table  2 , Supplemental Digital Content 2, http://links.lww.com/CCM/ C852; and Appendix Table 3 , Supplemental Digital Content 3, http://links.lww.com/CCM/C853). Six corresponding "base models" were developed to evaluate the independent association between the SOFA score on ICU day 1 (ICU admission) and ICU mortality in each subcohort. Age, CCI, ICU type (surgical, nonsurgical, or mixed), and the SOFA score on ICU day 1 were forced a priori in this and all models regardless of statistical significance. The base models were used to build other models by incrementally adding SOFA scores from ICU days 2, 3, and so on, up to ICU day 7. All models were then regularized to prevent overfitting. In particular, an elastic net regularization method was used, and an internal 10-fold cross-validation was employed to find the optimal value of the regularization variable (lambda) (9) . This method ensures generalizability of the model to out-of-sample data (validation cohort).
Models were compared with each other using the integrated discrimination index (IDI), a reclassification score that assesses improvement in model performance when a new biomarker is added to an existing model. In this example, the IDI is the sum of the improvement in the average sensitivities and the reduction in the average false-positive rates as a SOFA score is added to a subcohort model. (More positive values indicate improvement in performance.) IDIs were only used to compare models within a subcohort (i.e., those derived from samples of equal size). A set of predetermined comparisons assessed the incremental improvement in mortality prediction with the addition of a single SOFA score up to the complete model for that subcohort. (Appendix Table 4 , Supplemental Digital Content 4, http://links.lww.com/CCM/C854; and Appendix Table 5 , Supplemental Digital Content 5, http://links.lww.com/CCM/ C855) Post hoc comparisons were also performed within subcohorts to note improvement in model performance with addition of more than one SOFA score. (All reported IDIs were multiplied by 100.)
The results of all model comparisons were confirmed in an external validation cohort to assess the generalizability of those results. Bonferonni correction was applied in the validation group to account for multiple IDI comparisons (21 prespecified comparisons with ICU mortality as outcome, and 21 
RESULTS
After all exclusions applied to the derivation cohort, 1,290 patients were included for analysis (Fig. 2) . A total of 83 patients (6.4%) died during their ICU stay, and 122 (9.4%) died during hospitalization ( Table 1) . Patients who died in the derivation cohort had a higher percentage of abnormal WBC counts on ICU admission (73.5% vs 56.3%; p < 0.01), had longer median days on the ventilator (2 vs 0 d; p < 0.01), longer median ICU lengths of stay (5 vs 3 d; p = 0.01), and shorter median hospital lengths of stay (5 vs 10 d; p < 0.01). Patients in the validation group who died tended to be older (median age 74 vs 65; p < 0.01) with a lower proportion of African Americans (9.4% vs 14.6%; p < 0.01); neither relationship was seen in the derivation cohort. Compared with the external validation group (8,441 patients), the derivation cohort had a lower percentage of whites (31.5% vs 73.5%), less medical ICU patients (53.9% vs. 66.3%), and had higher maximum and mean SOFA scores (8 vs 5 and 5.2 vs 3.5, respectively) but lower ICU and hospital mortality (6.4% vs 11.3% and 9.4% vs 20.1%). (Table 1; and Appendix Table 6 , Supplemental Digital Content 7, http:// links.lww.com/CCM/C857)
In the derivation cohort, there was an independent incremental improvement (IDI with p < 0.05) in the addition of daily SOFA up to ICU day 4, but only in subcohorts 1 through 4. ( Table 2 , bolded items in top panel; Fig. 3A ). There was statistically significant improvement (p < 0.05) in the IDI of all subcohorts in the adjusted models up to ICU day 4 when aggregated SOFA scores over multiple consecutive days were added to the analysis post hoc (Appendix Incremental addition of daily SOFA scores in the validation cohort showed no improvement in adjusted ICU mortality prediction after ICU day 5 in the predetermined analysis ( Table 2 , bolded items in bottom panel; Fig. 3B ). The point of minimal improvement in ICU mortality was extended to ICU day 6 when aggregate SOFA data were added to adjusted models in post hoc analysis (Appendix Data after ICU day 3 no longer showed improvements in IDI with additional SOFA data to predict hospital mortality in the Figure 1 . Subcohort schematic. Each subsequent subcohort is a subsample of prior subcohorts. Model analysis was performed by subcohort to statistically compare the incremental benefit of daily serial Sequential Organ Failure Assessment (SOFA) data. As SOFA data from serial days were added to multivariate logistic regression models, the sample size stayed constant since days were added for each subcohort only up to the point of patient attrition. Note that patient attrition occurs at different rates depending on the subcohort (not drawn to scale). derivation cohort (Appendix Table 7 
DISCUSSION
In this study, we sought to identify the conditions in which organ failure data collected over time would improve ICU mortality prediction. We found statistically significant improvement in ICU mortality prediction when daily SOFA a Defined as two of four systemic inflammatory response syndrome (SIRS) criteria with 4 hr + blood cultures drawn, and all within 24 hours of each other.
b Patients came from the following areas: interventional radiology laboratory, interventional pulmonary laboratory, cardiac catheterization laboratory, or from the operating room for a scheduled case.
c Patients came from the following areas: direct admission from registration office, outpatient clinic, echocardiographic laboratory, or electrophysiology laboratory.
d Used as a surrogate for ward transfers to the ICU, since specific unit locations prior to ICU admission were unavailable. ED = emergency department, L & D = labor and delivery, LTAC = long-term acute care facility.
scores from ICU admission to day 5 were incrementally added to a multivariate model applied to our validation cohort. No such demonstrable improvement in ICU mortality prediction occurred by adding SOFA data after ICU day 5. Serial addition of organ failure data consistently improved hospital mortality prediction throughout our data collection period.
To our knowledge, this is the first study to demonstrate appropriate conditions for serial organ failure assessment. Though SOFA score is a useful prognostic tool in the ICU, prognostic capabilities could be improved by further organ failure data (2, 3, 10, 11) . This is the first study to demonstrate a point after which serial daily ICU data no longer improve ICU risk prediction. We used a large cohort to assess the independent relationship between additional organ failure and ICU mortality prediction and confirmed this in a much larger external cohort. Our study accounts for attrition bias by performing analyses in six subcohorts of the larger dataset. This has the added effect of seeing how length of stay affects the amount of SOFA data needed before it no longer impacts ICU mortality prediction. Those who stayed in the ICU past ICU day 6 in the derivation and validation cohorts did not experience any statistically significant improvement with incremental addition of daily SOFA scores. (Table 2) This study used the IDI to assess the added value of serial SOFA scores to ICU risk prediction. The IDI provides more relevant clinical information over other summary metrics such as the area under the receiver operator curve (AUC) since it assesses improvements in the sensitivity and specificity regardless of the risk threshold. IDI-based comparisons proved similar to AUC comparisons in one sepsis-related study (12) . However, improvements in the AUC can be nominal in magnitude, even when a new biomarker adds clinically meaningful predictive power to model performance (13) . Furthermore, the IDI may be easier to interpret since it directly relates to sensitivity and specificity. In our study, an IDI of 5.38% with the addition of SOFA day 2 to an adjusted model with SOFA day 1 (for validation subcohort 1) means that there was a collective improvement in sensitivity or specificity of 5.38%. This was associated with a corresponding increase in the AUC from 0.69 to 0.77 ( Table 2) .
The appropriateness of how and at what point to use serial SOFA assessment has important implications for clinicians, patients and family, administrators, and researchers. Clinicians can use SOFA score in a validated risk prediction tool to decide if it is appropriate to recommend aggressive care in the setting of persistent or worsened organ failure despite appropriate therapy. Goals of care discussions may be more timely with a prediction model incorporating incremental organ failure data, since clinicians would have all the information needed by ICU day 5.
Hospital administrators may find our results useful toward accelerating value. Sepsis is the most expensive condition treated in U.S. hospitals, and the cost is rising annually (14) . Others have suggested using changes in SOFA throughout the hospital course as a way of streamlining care (15) . For example, an electronic medical record alert could prompt clinicians to have early goals of care discussions if risk-of-death is above a certain point, based on SOFA score dynamics during the first few days of ICU care. Strategic healthcare application may reduce spending without sacrificing care quality. Once other investigators apply our findings to create ICU mortality risk assessment models, they may add relevant biomarker data to refine them. The AUCs of our adjusted models were quite modest, the largest of which was 0.82 (Table 2) . Perhaps the addition of newer organ failure biomarkers with proven prognostic value, such as neutrophil gelatinase-associated lipocalin (16, 17) , interleukin-2, and angiopoetin-2 (18), could further improve the predictive accuracy of our models and make them useful as a risk prediction tool.
The diminishing prognostic returns we found with early organ failure data has been established in prior studies, but our study is the first to use data as it is collected which could eventually be used in real time for ICU mortality prediction. Others have used summary SOFA measures that require knowledge of data from the entire ICU stay (2). Levy et al (4) showed that changes after ICU day 1 had little impact on 28-day mortality, but they did not use raw SOFA values. Although death is likely determined by an interaction between acute illness severity, age, comorbidities, and appropriate care, early therapeutic response seems to influence likelihood of ICU death in our sample.
Our post hoc analysis suggests prognostic improvement with aggregate SOFA scores from consecutive days when there was no improvement with any single score. It extended the utility of ICU organ failure data to day 6 in the validation cohort (Appendix Fig. 1 , subcohorts 5 and 6, Supplemental Digital Content 8, http://links.lww.com/CCM/C858; legend, Supplemental Digital Content 11, http://links.lww.com/CCM/ C861). This is expected since those who stay longer in the ICU are more likely to have subtle day-to-day changes in organ failure as a response to initial therapy (antibiotics, fluid resuscitation, etc.) which would be more clinically meaningful when observed over a longer time.
While the derivation and validation cohorts had much in common, there were some potentially important differences. The overall ICU and hospital mortality in the derivation group was lower than that of the validation group, even though the former group had higher median SOFA scores. This is likely due to a difference in recruitment peri- mortality was higher (19) . There was also a difference in the distribution of SOFA score utility. In the derivation cohort, the most recent SOFA score (up to day 4) provided the most useful information, but all scores (up to ICU day 5) in the validation cohort seemed to have equal importance (Table 2) . These patterns were not explained by differences in mortality, total attrition rates or attrition deaths ( Fig. 3; and Appendix Fig. 2 , Supplemental Digital Content 10, http://links.lww. com/CCM/C860; legend, Supplemental Digital Content 11, http://links.lww.com/CCM/C861), hospital or ICU lengths of stay (data not shown). Despite these differences, the general outcome was the same: indefinite serial organ failure data collection does not lead to consistent improvement in ICU mortality prediction.
There are limitations to our study. First, we did not have access to relevant clinical and laboratory information because of absent data (e.g., serum lactate, medication and antibiotic administration) or recording inaccuracies (e.g., amount of fluids given). We were only able to obtain laboratory values used to calculate the SOFA score. However, it is unlikely that uncollected laboratory data would have been enough of a confounder to erase the incremental benefit of serial SOFA data given the established relationship between SOFA and mortality (1, 2). Second, this was a retrospective sample in which we assumed clinical suspicion of infection based on ordered blood cultures. If a clinician orders a blood culture, that action indirectly confers a suspicion of infection. This surrogate clinical measure has been used in other relevant prospective sepsis studies (20) . Third, we performed multiple comparisons, which could have biased the results with too many false model improvements from further organ failure data. However, we used Bonferroni adjustment to deal with this, one of the more conservative statistical methods available (21) . Fourth, the IDI does not tell us whether any improvement seen in model performance is from better sensitivity or specificity. This could be answered in future studies. Finally, the median length of stay was 3 days, with only about 36% of patients in the ICU past day 5 (the point of minimal return for further organ failure data) in the validation cohort. However, this group comprised over 2,000 patients, which should be large enough to detect value of serial SOFA data past ICU day 5 if it existed. Further study is needed to validate and expand upon our findings. The goal of our study was not to derive a prediction model, but to demonstrate the point at which predictive accuracy no longer improves with further organ failure data. Any variables used in our models were used to remove confounding effects on prognostic improvements with serial addition of SOFA scores. Ultimately, all pertinent clinical and laboratory data should be calibrated specifically for use in a predictive tool. Other novel physiologic and laboratory biomarkers can be incorporated into this predictive algorithm, preferably using a prospectively collected cohort of patients.
CONCLUSIONS
Our data suggest that the incremental value of daily organ failure data for predicting ICU mortality is lost after ICU day 5. Perhaps this point of minimal return is extended to ICU day 6 if aggregate SOFA data from consecutive days are added to existing ICU mortality prediction models. The addition of early daily SOFA data always improved prediction of hospital mortality prediction during our data collection period (from ICU admission to ICU day 7). These findings are useful for clinical decision-making, hospital administration, and research. Future testing is required to derive high-performing prediction models for clinical use. Demonstrates the effect of adding a single SOFA value to a model for mortality prediction. All integrated discriminatory indices (IDIs) that were not statistically significant (p < 0.05 in derivation; p < 0.001 in validation) were assigned a value of 0 for simplification. The two figures demonstrate the effects of additional SOFA on each subcohort (SC), represented by the six plots on each figure. The sample size, ICU mortality, number of patients lost and percentage of those who died on any given day is listed in a table under each figure. If present, a circle marks the last day after which additional SOFA data no longer contributes to ICU mortality.
